There is a need for effective and well-tolerated treatments that can be used in the early stages of dementia. Overall, the evidence suggests that taking a standardized, proprietary ginkgo extract may be an effective intervention for the primary and secondary prevention of cognitive impairment and mild to moderate dementia. To confirm the efficacy in patients with mild dementia, Riepe et al. conducted a meta-analysis.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Patient-centered rounds in medicine
Aligning care with the patient
- HIV: antiretroviral therapy (ART)
Single-tablet regimens support adherence
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Vaccinations against viral respiratory infections
Influenza, Covid-19 and RSV – Update 2025
- GLP1-RA therapy
Improvement in either weight or HbA1c – but never both
- Suicide
Dealing with trauma after suicide loss: What do bereaved people experience as effective?
- COPD exacerbations
Fast therapy initiation is not much better than expected
- Lung cancer with EGFR mutation